期刊文献+

流感病毒多表位核酸疫苗CTB-Eg的构建与细胞转染研究 被引量:1

Construction and transfection of a multi-epitope DNA vaccine CTB-Eg of influenza
下载PDF
导出
摘要 目的设计并构建含分子内佐剂的流感病毒多表位核酸疫苗CTB-Eg,初步研究其在HEK293T细胞中的转染效率。方法通过生物信息学软件设计并合成了含分子内佐剂的流感病毒多表位基因CTB-Eg,将其插入真核载体pEGFP-C2中,获得了重组质粒pEGFP-C2/CTB-Eg;用脂质体法转染HEK293T细胞,通过荧光显微镜观察和PCR法检测其转染效率。结果成功构建了真核表达质粒pEGFP-C2/CTB-Eg,且该重组质粒能在HEK293T细胞中瞬时转染,转染效率在50%~70%之间。结论本研究成功设计、构建了CTB-Eg融合基因,其在HEK293T细胞中转染效率较高,为流感病毒多表位核酸疫苗CTB-Eg在小鼠体内的抗病毒作用研究奠定了坚实基础。 Objective To design and construct the eukaryotic expression vector of CTB-Eg fusion gene of influenza virus,and study the transfection efficiency of pEGFP-C2/CTB-Eg in HEK293 Tcells.Methods CTB-Eg fusion gene containing CTB(cholera toxin B subunit)as the molecule adjuvant was designed and synthesized.The eukaryotic expression vector of pEGFP-C2/CTB-Eg was constructed.The certified recombinant plasmid was transfected in HEK293 Tcells by Liposomal Transfection Reagent.The transfection efficiency of CTB-Eg gene was detected by fluorescence microscope and PCR.Results Expression vector pEGFP-C2/CTB-Eg was constructed successfully.The recombinant plasmid could be transfected in HEK293 Tcells and its transfection efficiency could reach to 50%-70%.Conclusion The eukaryotic expression vector of pEGFP-C2/CTB-Eg was constructed successfully and transfected in HEK293 Tcells.
出处 《西部医学》 2015年第2期182-185,189,共5页 Medical Journal of West China
基金 四川省科技厅支撑计划项目(2014SZ0036)
关键词 流感病毒 核酸疫苗 多表位基因 霍乱毒素B亚单位 Influenza virus DNA vaccine multi-epitope genes Cholera toxin B subunit
  • 相关文献

参考文献18

  • 1Meng S, I: Z. , Xu L, et al. Intranasal immunization with re- combinant HA and mast cell activator C48/80 elicits protective immunity against 2009 pandemic H1N1 influenza in mice [J]. PLoS One, 2011, 6(5)z e19863.
  • 2Ferraris O, E. V. , Bouscambert M, et al. H1N1 influenza A virus neuraminidase modulates infectivity in mice [J]. Antiviral Res, 2012, 93(3); 374 380.
  • 3Imai M, Watanabe T, Hatta M, et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets [J]. Nature, 2012, 486(7403) ; 420 428.
  • 4Seasonal influenza World Health Organization, Copenhagen, Denmark (2009). (www. euro. who. int/influenza/2008618 1).
  • 5Girard MP, Cherian T, Pervikov Y, et al. A review of vaccine research and development: human acute respiratory infections [J]. Vaccine, 2005, 23 (50): 5708-5724.
  • 6陈则.通用流感疫苗研究进展[J].湖南师范大学学报(医学版),2012,9(3):1-5. 被引量:2
  • 7邵京京,丰锋,张强,李虹,李明远,王保宁,李婉宜.流感病毒多表位基因盒的设计与预测[J].华西药学杂志,2012,27(5):486-489. 被引量:1
  • 8Alarcon JB, Waine GW, McManus DP. DNA vaccines: technol- ogy and application as anti-parasite and anti microbial agents[J]. Adv Parasitol, 1999, 42: 343-410.
  • 9Kishwar Hayat Khan. DNA vaccine: roles against diseases [J]. Germs, 2013, (3)1: 27-35.
  • 10Graeme E. Price, Chia-Yun Lo, et al. Mucosal Immunization with a Candidate Universal Influenza Vaccine Reduces Virus Transmission in a Mouse Model [J]. Journal of Virology, 2014, 88(11) : 6019-6030.

二级参考文献19

  • 1Zhong W, Chem JB. Genome - wide characterization of a viral cy- totoxic T lymphocyte epitope repertoire [ J ]. J Biol Chem,2003, 278:45135 -45144.
  • 2Crowe SR, Miller SC, Brown DM,et al. Uneven distribution of MHC classII epitopes within the in uenza virus [ J ]. Vaccine , 2006,24:457 - 467.
  • 3Li H,Ding J,Chen YH. Recombinant protein comprising multi - neutralizing epitopes induced high titer of antibodies against influ- enza A virus [ J ]. Immunobiology ,2003 ,207 :305 - 313.
  • 4Lu Y, Ding J, Liu W,et al. A candidate vaccine against influenza virus intensively improved the immunogenicity of a neutralizing epitope [ J ]. Int Arch Allergy Immunol,2002,127:245 - 250.
  • 5Deliyannis G, Jackson DC, Ede N J, et al. Induction of long- term memory CD8( + ) T cells for recall of viral clearing responses a- gainst influenza virus[ J]. J Virol ,2002,76:4212 -4221.
  • 6Lawrence CW, Ream RM, Braciale TJ. Frequency, specificity, and sites of expansion of CD8 + T cells during primary pulmonary in- fluenza virus infection [ J ]. J Immuno1,2005 ,174 :5332 - 5440.
  • 7Berkhoff EGM, Geelhoed - Mierss MM, Fouchier RAM, et aJ. Assessment of the extent of variation in influenza A virus cytotoxic T - lymphocyte epitopes by using virus - specific CD8 + T - cell clones[J]. J Gen Viro1,2007 ,88 :530 - 535.
  • 8Kreijtz JHCM, Bodewes R, Brand JMA, et al. Infection of mice with a human influenza A/H3N2 virus induces protective immu- nity against lethal infection with influenza A/H5N1 virus [J]. Vaccine ,2009,27:4983 - 4989.
  • 9Khan N,Hislop A,Gudgeon N,et al. Herpesvims- specific CD8 T cell immunity in old age:Cytomegalovirus impairs the response to a coresident EBV infection [ J ], J Immunol,2004,173 (12) : 7481 - 7489.
  • 10Toebes M, Coccoris M, Bins A,et al. Design and use of condi- tional MHC class I ligands[ J]. Nat Med,2006,12:246- 251.

共引文献1

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部